One of the frequent genetic monogenic haemoglobin disorders is thalassemia major, often known as Cooley anaemia. It happens because the process of making haemoglobin does not include a beta-globin chain. The production of healthy red blood cells and haemoglobin by your body is impacted by the genetic blood condition thalassemia. There are alpha and beta thalassemia types. You may develop mild to severe anaemia-like symptoms due to thalassemia. Iron chelation therapy and blood transfusions are both possible forms of treatment.

Blood disease thalassemia is inherited. It has an impact on your body's capacity to make healthy haemoglobin. Red blood cells contain the protein haemoglobin. It enables your red blood cells to carry oxygen throughout your body, supplying the other cells with nutrients. Your body and bone marrow both create less healthy haemoglobin proteins and healthy red blood cells if you have thalassemia. Anaemia is a condition in which there are insufficient red blood cells. Lack of healthy red blood cells can deprive your body's cells of the oxygen they require to create energy and thrive because red blood cells play a crucial function in delivering oxygen to tissues in your body. Mild to severe anaemia, in addition to other issues, can be brought on by thalassemia over time. Anaemia’s signs: Fatigue, Breathlessness, Dizziness, pale skin.

Alpha and beta globin chains make up two of the four protein chains that make up haemoglobin. Both the alpha and beta chains are made up of genes that were inherited from your parents. Consider these genes as the "coding" or programming for each chain, which in turn regulates your haemoglobin. You will develop thalassemia if one or more of these genes are damaged or absent. Two genes from each parent make up each of the four alpha globin protein chains. Each parent contributes one gene to the beta globin protein chain. Whether you have thalassemia in your alpha or beta chains is determined by the genetic abnormality. Your condition's severity will depend on how bad the flaw is.

Because symptoms typically occur within the first two years of your child's life, moderate and severe thalassemia is frequently diagnosed in children. For the purpose of diagnosing thalassemia, your doctor may request a number of blood tests: a complete blood count (CBC) that counts red blood cell amount as well as haemoglobin. Less haemoglobin and healthier red blood cells are seen in thalassemia patients than in healthy individuals. They can also have red blood cells that are smaller than usual. Your bone marrow may not be making enough red blood cells, according to a reticulocyte count. The diagnosis of beta thalassemia is made via haemoglobin electrophoresis. Using genetic testing, alpha thalassemia is identified.

Iron chelation and blood transfusions are common thalassemia major therapies. Red blood cells are injected into a vein during a blood transfusion to replenish the body's normal supply of haemoglobin and healthy red blood cells. If you have moderately severe thalassemia or beta thalassemia major, you will require transfusions every four months, and every two to four weeks, respectively. For beta thalassemia intermedia or haemoglobin H illness, transfusions could be required occasionally. Iron chelation involves removing extra iron from your body. Iron overload is a risk associated with blood transfusions. Organs may be harmed by too much iron. You'll need iron chelation therapy if you have transfusions frequently. You can help your body create healthy blood cells by taking folic acid supplements.

Clinical Pathology & Laboratory Medicine Peer- reviewed which will be dedicated to advancing diagnosis of diseases based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of biochemistry, microbiology, haematology and molecular pathology.

Authors can submit their manuscripts as an email attachment to clincalpatho@scholarlypub.org.

Best Wishes,
Journal Co-ordinator
Clinical Pathology & Laboratory Medicine